ASCVD Clinical Trials in Beijing
5 recruitingBeijing, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
ASCVDAtherosclerosis Cardiovascular DiseaseASCVD Management
Atom Therapeutics Co., Ltd200 enrolled33 locationsNCT07303777
Recruiting
Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company10,450 enrolled751 locationsNCT07157774
Recruiting
Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
Cardiovascular DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)Secondary Prevention
Peking University First Hospital5,448 enrolled1 locationNCT07542860
Recruiting
Phase 3
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled92 locationsNCT06813911
Recruiting
Phase 3
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Primary hypercholesterolemiaMetabolic DiseaseDyslipidemias+4 more
Hasten Biopharmaceutical Co., Ltd.210 enrolled18 locationsNCT06568471